Clinical Trial Update: Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects [Phase 3]

View source ↗

Summary

Phase 3 dose-ranging study evaluating the safety and tolerability of TOPROL-XL Extended-Release tablets in pediatric hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• TOPROL XL (METOPROLOL SUCCINATE)

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Phase 3 | Status: COMPLETED